Why Has Gamida Cell (GMDA) Stock Dropped Today?

Gamida Cell Ltd. (NASDAQ: GMDA) shares plunged by -18.65% on Wednesday after the company announced the pricing of its offering. GMDA stock closed the last session at $1.61 trading 0.33 million shares.

How much has GMDA announced for its pricing?

In a follow-on public offering, Gamida Cell (GMDA) has announced the pricing of 12,905,000 ordinary shares.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.

  • For aggregate gross proceeds of $20 million, the offering will be priced at $1.55 per share before discount and commissions from underwriting, as well as estimated offering expenses.
  • Further, Gamida Cell has granted the underwriters an option to purchase 1,935,750 additional ordinary shares for the price of the public offering, less underwriting discounts, and commissions, for a period of 30 days.
  • According to the schedule, the offering is expected to close on or about September 30, 2022, assuming all closing conditions are met.
  • This offering will be used by GMDA in conjunction with its existing cash, cash equivalents, and trading financial assets to support possible commercial readiness activities for omidubicel, if approved.
  • In addition to the continued clinical development of Gamida Cell’s NK product candidates, including GDA-201, the proceeds will also be used for general corporate purposes, such as administrative expenses and working capital.

GMDA’s other efforts?

A separate release announced that GMDA had signed a commitment letter with Highbridge Capital Management, LLC (“Highbridge”).

  • Based upon the Commitment Letter, Highbridge has committed to providing a $25,000 senior secured, convertible term loan to GMDA.
  • There are certain conditions attached to the Commitment Letter, including the completion of a Gamida Cell equity offering resulting in gross proceeds of at least $20 million, which do not constitute a definitive credit facility.
  • There is maturity date of 24 months from the closing date on the Commitment Letter, among other things.
  • A quarterly interest rate of 7.50% is also included in the Commitment Letter, subject to an increase to 12.00% upon certain events.

How will GMDA go about financing?

There are certain conditions, and the payment will be made in ordinary shares of GMDA valued at 95% of the volume-weighted average price within a specified time frame. Gamida Cell (GMDA) will be using its own assets and those of its subsidiaries to secure the obligations under the term loan.

Most Popular

Related Posts